ABSTRACT

Genomics and proteomics are newly developing fields and becoming widely used in cancer research especially in cancer diagnosis. The aim is to review the role of genomics and proteomics to discover new breast cancer biomarkers for diagnosis with higher sensitivity and specificity. Studies reporting on potential biomarkers in breast cancer were included in this review. In the future, platforms in genomics and proteomics will be used for the discovery of tumor specific genes and related proteins, which will lead to development of novel therapeutic targets leading to patient specific therapies.